Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism

A simple objective technique for measuring flexibility in thinking

Berg, E. A. (1948) · The Journal of General Psychology · doi:10.1080/00221309.1948.9918159 · Cited by 2,255 · see citing works

Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

Niswender, C. M., & Conn, P. J. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145533 · Cited by 1,889 · see citing works

Psychedelics

Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762 · see citing works

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works

Control of memory formation through regulated expression of a CaMKII transgene

Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550 · see citing works

Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat

Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421 · see citing works

Psychedelics promote structural and functional neural plasticity

Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207 · see citing works

Delayed reward discounting and addictive behavior: a meta-analysis

MacKillop, J., Amlung, M. T., Few, L. R., Ray, L. A., Sweet, L. H., & Munafò, M. R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2229-0 · Cited by 1,021 · see citing works

Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings: A Systematic Review and Meta-analysis

Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923 · see citing works

Identification of a serotonin/glutamate receptor complex implicated in psychosis

González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803 · see citing works

Metabotropic glutamate receptors: electrophysiological properties and role in plasticity

Anwyl, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00050-2 · Cited by 776 · see citing works

Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls

Petry, N. M. (2001) · Psychopharmacology · doi:10.1007/s002130000638 · Cited by 761 · see citing works

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · see citing works

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706 · see citing works

Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior

Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 636 · see citing works

A non-hallucinogenic psychedelic analogue with therapeutic potential

Cameron, L. P., Tombari, R. J., Lu, J., Pell, A. J., Hurley, Z. Q., Ehinger, Y., Vargas, M. V., McCarroll, M. N., Taylor, J. C., Myers-Turnbull, D., et al. (2021) · Nature · doi:10.1038/s41586-020-3008-z · Cited by 473 · see citing works

Opiate versus psychostimulant addiction: the differences do matter

Badiani, A., Belin, D., Epstein, D. H., Calu, D. J., & Shaham, Y. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3104 · Cited by 466 · see citing works

Dopaminergic and Glutamatergic Regulation of Effort- and Delay-Based Decision Making

Floresco, S., Tse, M., & Ghods-Sharifi, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301565 · Cited by 433 · see citing works

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343 · see citing works

Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research

Berre, A. L., Fama, R., & Sullivan, E. V. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13431 · Cited by 332 · see citing works

Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol

Rimondini, R., Arlinde, C., Sommer, W. H., & Heilig, M. A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 320 · see citing works

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312 · cited 2× · see citing works

Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs

Fribourg, M., Moreno, J. L., Holloway, T., Provasi, D., Baki, L., Mahajan, R., Park, G., Adney, S. K., Hatcher, C., Eltit, J. M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.055 · Cited by 311 · see citing works

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways

López‐Giménez, J. F., & González‐Maeso, J. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_478 · Cited by 311 · see citing works

Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence

Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309 · see citing works

Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty

Mark, T. L., Kassed, C. A., Vandivort-Warren, R., Levit, K. R., & Kranzler, H. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.018 · Cited by 246 · see citing works

NEW STRAINS OF RATS WITH ALCOHOL PREFERENCE AND NONPREFERENCE

Lumeng, L., Hawkins, T., & Li, T.-K. (1977) · Elsevier eBooks · doi:10.1016/b978-0-12-691403-0.50056-2 · Cited by 240 · see citing works

Chronic Alcohol Exposure Alters Behavioral and Synaptic Plasticity of the Rodent Prefrontal Cortex

Kroener, S., Mulholland, P. J., New, N., Gass, J. T., Becker, H. C., & Chandler, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037541 · Cited by 236 · see citing works

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

Moreno, J. L., Holloway, T. D., Albizu, L., Sealfon, S. C., & González‐Maeso, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.046 · Cited by 235 · see citing works

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.002 · Cited by 226 · see citing works

Animal models of addiction

Spanagel, R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/rspanagel · Cited by 224 · see citing works

Glutamatergic targets for new alcohol medications

Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3226-2 · Cited by 197 · see citing works

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting

Prochazkova, L., Lippelt, D. P., Colzato, L. S., Kuchar, M., Sjoerds, Z., & Hommel, B. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5049-7 · Cited by 177 · see citing works

Addiction Research Consortium: Losing and regaining control over drug intake (ReCoDe)—From trajectories to mechanisms and interventions

Heinz, A., Kiefer, F., Smolka, M. N., Endraß, T., Beste, C., Beck, A., Liu, S., Genauck, A., Romund, L., Banaschewski, T., et al. (2019) · Addiction Biology · doi:10.1111/adb.12866 · Cited by 177 · see citing works

Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: A comprehensive meta-analysis

Noori, H. R., Cosa‐Linan, A., & Spanagel, R. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.06.013 · Cited by 176 · see citing works

Rescue of Infralimbic mGluR2Deficit Restores Control Over Drug-Seeking Behavior in Alcohol Dependence

Meinhardt, M. W., Hansson, A. C., Perreau‐Lenz, S., Bauder-Wenz, C., Stählin, O., Heilig, M. A., Harper, C. G., Drescher, K. U., Spanagel, R., & Sommer, W. H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4062-12.2013 · Cited by 170 · see citing works

Biphenyl-indanone A, a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor Subtype 2, Has Antipsychotic- and Anxiolytic-Like Effects in Mice

Galici, R., Jones, C. K., Hemstapat, R., Nong, Y., Echemendia, N. G., Williams, L. C., de Paulis, T., & Conn, P. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102046 · Cited by 169 · see citing works

Translating Glutamate: From Pathophysiology to Treatment

Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168 · see citing works

Chronic, Intermittent Microdoses of the Psychedelic <i>N</i> , <i>N</i> -Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00692 · Cited by 168 · see citing works

Prefrontal synaptic markers of cocaine addiction-like behavior in rats

Kasanetz, F., Lafourcade, M., Deroche‐Gamonet, V., Revest, J., Berson, N., Balado, É., Fiancette, J. F., Renault, P., Piazza, P.-V., & Manzoni, O. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.59 · Cited by 165 · see citing works

Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors

Gewirtz, J. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00136-6 · Cited by 164 · see citing works

Glutamate and reinstatement

Knackstedt, L. A., & Kalivas, P. W. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.003 · Cited by 159 · see citing works

A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis

Benneyworth, M. A., Xiang, Z., Smith, R. L., Garcia, E. E., Conn, P. J., & Sanders‐Bush, E. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035170 · Cited by 159 · see citing works

Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction

Moussawi, K., & Kalivas, P. W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.01.030 · Cited by 146 · see citing works

Meta-analyses of clinical neuropsychological tests of executive dysfunction and impulsivity in alcohol use disorder

Stephan, R. A., Alhassoon, O. M., Allen, K. E., Wollman, S. C., Hall, M., Thomas, W. J., Gamboa, J. M., Kimmel, C., Stern, M., Sari, C., et al. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1206113 · Cited by 145 · see citing works

Rule Learning and Reward Contingency Are Associated with Dissociable Patterns of Dopamine Activation in the Rat Prefrontal Cortex, Nucleus Accumbens, and Dorsal Striatum

Stefani, M. R., & Moghaddam, B. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1656-06.2006 · Cited by 142 · see citing works

Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence

Hirth, N., Meinhardt, M. W., Noori, H. R., Salgado, H., Torres‐Ramírez, O., Uhrig, S., Broccoli, L., Vengeliene, V., Roßmanith, M., Perreau‐Lenz, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506012113 · Cited by 142 · see citing works

Temporal discounting as a measure of executive function: Insights from the competing neuro-behavioral decision system hypothesis of addiction

Bickel, W. K., & Yi, R. (2008) · Advances in health economics and health services research · doi:10.1016/s0731-2199(08)20012-9 · Cited by 122 · see citing works

Animal models for medications development targeting alcohol abuse using selectively bred rat lines: Neurobiological and pharmacological validity

Bell, R. L., Sable, H. J. K., Colombo, G., Hyytiä, P., Rodd, Z. A., & Lumeng, L. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.07.007 · Cited by 119 · see citing works

Loss of metabotropic glutamate receptor 2 escalates alcohol consumption

Zhou, Z., Karlsson, C., Liang, T., Xiong, W., Kimura, M., Tapocik, J. D., Yuan, Q., Barbier, E., Feng, A. Y., Flanigan, M. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309839110 · Cited by 115 · see citing works

Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice

Kłodzińska, A., Bijak, M., Tokarski, K., & Pilc, A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00845-6 · Cited by 97 · see citing works

Internet addictive individuals share impulsivity and executive dysfunction with alcohol-dependent patients

Zhou, Z., Zhu, H., Li, C., & Wang, J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00288 · Cited by 96 · see citing works

Developing neuroscience-based treatments for alcohol addiction: A matter of choice?

Heilig, M. A., Augier, E., Pfarr, S., & Sommer, W. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0591-6 · Cited by 95 · see citing works

Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats

Bäck, S., Necarsulmer, J., Ramsey, L. A., Coke, L. M., Koivula, P. P., Heathward, E. J., Fortuno, L. V., Zhang, Y., Yeh, C., Baldwin, H. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.035 · Cited by 92 · see citing works

Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone

Bach, P., Weil, G., Pompili, E., Hoffmann, S., Hermann, D., Vollstädt‐Klein, S., Mann, K. F., Pérez‐Ramírez, Ú., Moratal, D., Canals, S., et al. (2019) · Addiction Biology · doi:10.1111/adb.12717 · Cited by 85 · see citing works

Postdependent state in rats as a model for medication development in alcoholism

Meinhardt, M. W., & Sommer, W. H. (2014) · Addiction Biology · doi:10.1111/adb.12187 · Cited by 83 · see citing works

Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats

Nikiforuk, A., Popik, P., Drescher, K. U., van Gaalen, M. M., Relo, A. L., Mezler, M., Marek, G. J., Schoemaker, H., Groß, G., & Bespalov, A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170506 · Cited by 75 · see citing works

Enhanced Sensitivity to Attenuation of Conditioned Reinstatement by the mGluR2/3 Agonist LY379268 and Increased Functional Activity of mGluR2/3 in Rats with a History of Ethanol Dependence

Kufahl, P. R., Martin-Fardon, R., & Weiss, F. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.174 · Cited by 72 · see citing works

Ethanol-associated changes in glutamate reward neurocircuitry: a minireview of clinical and preclinical genetic findings

Bell, R. L., Hauser, S. R., McClintick, J., Rahman, S., Edenberg, H. J., Szumlinski, K. K., & McBride, W. J. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.018 · Cited by 65 · see citing works

Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse

Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0694-z · Cited by 65 · see citing works

Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat

Jefsen, O. H., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D., Wegener, G., & Müller, H. K. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.15 · Cited by 63 · see citing works

The mGluR2/3 Agonist LY379268 Induced Anti-Reinstatement Effects in Rats Exhibiting Addiction-like Behavior

Cannella, N., Halbout, B., Uhrig, S., Evrard, L., Corsi, M., Corti, C., Deroche‐Gamonet, V., Hansson, A. C., & Spanagel, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.106 · Cited by 62 · see citing works

Alcohol Decreases Baseline Brain Glucose Metabolism More in Heavy Drinkers Than Controls But Has No Effect on Stimulation-Induced Metabolic Increases

Volkow, N. D., Wang, G., Kojori, E. S., Fowler, J. S., Benveniste, H., & Tomasi, D. G. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4877-14.2015 · Cited by 60 · see citing works

The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats

Rohleder, C., Wiedermann, D., Neumaier, B., Drzezga, A. E., Timmermann, L., Graf, R., Leweke, F. M., & Endepols, H. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00148 · Cited by 59 · see citing works

How ecstasy and psilocybin are shaking up psychiatry

Tullis, P. (2021) · Nature · doi:10.1038/d41586-021-00187-9 · Cited by 58 · see citing works

Effect of Novel Allosteric Modulators of Metabotropic Glutamate Receptors on Drug Self-administration and Relapse: A Review of Preclinical Studies and Their Clinical Implications

Caprioli, D., Justinova, Z., Venniro, M., & Shaham, Y. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.018 · Cited by 55 · see citing works

The Effects of Hallucinogens on Gene Expression

Martin, D. A., & Nichols, C. D. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_479 · Cited by 51 · see citing works

AAV-Mediated Overexpression of the CB1 Receptor in the mPFC of Adult Rats Alters Cognitive Flexibility, Social Behavior, and Emotional Reactivity

Klugmann, M., Goepfrich, A., Friemel, C. M., & Schneider, M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00037 · Cited by 49 · see citing works

Studying the Effects of Classic Hallucinogens in the treatment of alcoholism: Rationale, methodology, and current research with psilocybin

Bogenschutz, M. (2013) · Current Drug Abuse Reviews · doi:10.2174/15733998113099990002 · Cited by 47 · see citing works

The role of group II metabotropic glutamate receptors in cognition and anxiety: Comparative studies in GRM2−/−, GRM3−/− and GRM2/3−/− knockout mice

Filippis, B. D., Lyon, L., Taylor, A. M., Lane, T. A., Burnet, P. W. J., Harrison, P. J., & Bannerman, D. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.010 · Cited by 46 · see citing works

Conditional gene expression systems in the transgenic rat brain

Schönig, K., Weber, T., Frömmig, A., Wendler, L., Pesold, B., Djandji, D., Bujard, H., & Bartsch, D. (2012) · BMC Biology · doi:10.1186/1741-7007-10-77 · Cited by 44 · see citing works

The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats

Augier, E., Dulman, R. S., Rauffenbart, C., Augier, G., Cross, A. J., & Heilig, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.107 · Cited by 44 · see citing works

Interclass GPCR heteromerization affects localization and trafficking

Toneatti, R., Shin, J. M., Shah, U. H., Mayer, C. R., Saunders, J. M., Fribourg, M., Arsenovic, P. T., Janssen, W. G. M., Sealfon, S. C., López‐Giménez, J. F., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaw3122 · Cited by 43 · see citing works

The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research

Heilig, M. A., Sommer, W. H., & Spanagel, R. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5006 · Cited by 42 · see citing works

Investigation of brain functional connectivity to assess cognitive control over cue‐processing in Alcohol Use Disorder

Strosche, A., Zhang, X., Kirsch, M., Hermann, D., Ende, G., Kiefer, F., & Vollstädt‐Klein, S. (2020) · Addiction Biology · doi:10.1111/adb.12863 · Cited by 41 · see citing works

Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells

Baki, L., Fribourg, M., Younkin, J., Eltit, J. M., Moreno, J. L., Park, G., Vysotskaya, Z. V., Narahari, A. K., Sealfon, S. C., González‐Maeso, J., et al. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1780-7 · Cited by 36 · see citing works

Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics

Walker, A. G., & Conn, P. J. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.11.003 · Cited by 35 · see citing works

Positron emission tomography--a tool for identifying the effects of alcohol dependence on the brain.

Wong, D. F., Maini, A., ROUSSET, O. G., & Brašić, J. R. (2003) · Europe PMC (PubMed Central) · Cited by 32 · see citing works

Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice

Benvenga, M. J., Chaney, S. F., Baez, M., Britton, T. C., Hornback, W. J., Monn, J. A., & Marek, G. J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00208 · Cited by 28 · see citing works

Neural correlates of reward magnitude and delay during a probabilistic delay discounting task in alcohol use disorder

Dennis, L. E., Kohno, M., McCready, H. D., Schwartz, D. L., Schwartz, B., Lahna, D. L., Nagel, B. J., Mitchell, S. H., & Hoffman, W. F. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05364-3 · Cited by 18 · see citing works

Factors Affecting the Short–Term Prognosis of Alcohol Dependent Patients Undergoing Inpatient Detoxification

Wicks, S., Hammar, J., Heilig, M. A., & Wisén, O. (2001) · Substance Abuse · doi:10.1080/08897070109511465 · Cited by 14 · see citing works

Changes in cerebral [18F]-FDG uptake induced by acute alcohol administration in a rat model of alcoholism

Gispert, J. D., Figueiras, F. P., Vengeliene, V., Herance, J. R., Rojas, S., & Spanagel, R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.038 · Cited by 13 · see citing works

Psychedelics move from agents of rebellion towards therapeutics

McCall, B. (2020) · Nature Medicine · doi:10.1038/d41591-020-00001-5 · Cited by 3 · see citing works

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial

Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2096 · Cited by 711 · see citing works

Psychedelic therapy in the treatment of addiction: the past, present and future

Zafar, R. R., Siegel, M., Harding, R., Barba, T., Agnorelli, C., Suseelan, S., Roseman, L., Wall, M. B., Nutt, D., & Erritzøe, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1183740 · Cited by 108 · see citing works

Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action

Cameron, L. P., Benetatos, J., Lewis, V., Bonniwell, E. M., Jaster, A. M., Moliner, R., Ċastrén, E., McCorvy, J. D., Palner, M., & Aguilar‐Valles, A. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1384-23.2023 · Cited by 93 · see citing works

Therapeutic mechanisms of psychedelics and entactogens

Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 67 · see citing works

Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective

Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works

Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies

Calleja‐Conde, J., Morales-Garcia, J. A., Echeverry‐Alzate, V., Bühler, K., Giné, E., & López‐Moreno, J. A. (2022) · Addiction Biology · doi:10.1111/adb.13229 · Cited by 54 · see citing works

Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice

Fadahunsi, N., Lund, J. T., Breum, A. W., Mathiesen, C. V., Larsen, I. B., Knudsen, G. M., Klein, A. B., & Clemmensen, C. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02103-9 · Cited by 47 · see citing works

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics

Urban, M. M., Stingl, M., & Meinhardt, M. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1156319 · Cited by 44 · see citing works

Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice

Alper, K., Cange, J., Sah, R., Schreiber-Gregory, D., Sershen, H. W., & Vinod, K. Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1074633 · Cited by 40 · see citing works

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders

Wulff, A. B., Nichols, C. D., & Thompson, S. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109504 · Cited by 34 · see citing works

The ReCoDe addiction research consortium: Losing and regaining control over drug intake—Findings and future perspectives

Spanagel, R., Bach, P., Banaschewski, T., Beck, A., Bermpohl, F., Bernardi, R. E., Beste, C., Deserno, L., Durstewitz, D., Ebner‐Priemer, U., et al. (2024) · Addiction Biology · doi:10.1111/adb.13419 · Cited by 33 · see citing works

Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review

Ziff, S., Stern, B., Lewis, G., Majeed, M., & Gorantla, V. R. (2022) · Cureus · doi:10.7759/cureus.21944 · Cited by 38 · see citing works

Synaptic Effects Induced by Alcohol

Lovinger, D. M., & Roberto, M. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_412 · Cited by 30 · see citing works

Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats

Floris, G., Dabrowski, K. R., Zanda, M. T., & Daws, S. E. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02788-y · Cited by 30 · see citing works

Animal Behavior in Psychedelic Research

Odland, A. U., Kristensen, J. L., & Andreasen, J. T. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000590 · Cited by 28 · see citing works

Psilocybin for the treatment of Alzheimer’s disease

Zheng, S., Ma, R., Yang, Y., & Li, G. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1420601 · Cited by 27 · see citing works

Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats

Reinwald, J., Schmitz, C. N., Skorodumov, I., Kuchař, M., Weber‐Fahr, W., Spanagel, R., & Meinhardt, M. W. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02690-1 · Cited by 25 · see citing works

Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review

Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16017 · Cited by 23 · see citing works

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism

Domanegg, K., Sommer, W. H., & Meinhardt, M. W. (2023) · Cells · doi:10.3390/cells12060963 · Cited by 24 · see citing works

From a systems view to spotting a hidden island: A narrative review implicating insula function in alcoholism

Sommer, W. H., Canals, S., Bifone, A., Heilig, M. A., & Hyytiä, P. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108989 · Cited by 21 · see citing works

Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study

Jensen, M. E., Stenbæk, D. S., Messell, C., Poulsen, E. D., Varga, T. V., Fisher, P. M., Nielsen, M. K. K., Johansen, S. S., Volkow, N. D., Knudsen, G. M., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251319457 · Cited by 21 · see citing works

Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience

Viktorin, V., Griškova-Bulanova, I., Voicikas, A., Dojčánová, D., Zach, P., Bravermanová, A., Andrashko, V., Tylš, F., Korčák, J., Viktorinová, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12061004 · Cited by 20 · see citing works

Bad habits–good goals? Meta-analysis and translation of the habit construct to alcoholism

Giannone, F., Ebrahimi, C., Endraß, T., Hansson, A. C., Schlagenhauf, F., & Sommer, W. H. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02965-1 · Cited by 20 · see citing works

Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice

Elsilä, L. V., Harkki, J., Enberg, E., Martti, A., Linden, A.-M., & Korpi, E. R. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104641 · Cited by 19 · see citing works

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder

Köhne, S., Hillemacher, T., Glahn, A., & Bach, P. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2342951 · Cited by 17 · see citing works

Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories

Benvenuti, F., Colombo, D., Soverchia, L., Cannella, N., Domi, E., & Ciccocioppo, R. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06384-w · Cited by 18 · see citing works

Alcohol-induced damage to the fimbria/fornix reduces hippocampal-prefrontal cortex connection during early abstinence

Pérez-Cervera, L., Santis, S. D., Marcos, E., Ghorbanzad-Ghaziany, Z., Carpena, A. T., Selim, M. K., Pérez‐Ramírez, Ú., Pfarr, S., Bach, P., Halli, P., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01597-8 · Cited by 16 · see citing works

mGlu2 mechanism-based interventions to treat alcohol relapse

Vengeliene, V., & Spanagel, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.985954 · Cited by 14 · see citing works

Pre- and postsynaptic signatures in the prelimbic cortex associated with “alcohol use disorder” in the rat

Domi, A., Cadeddu, D., Lucente, E., Gobbo, F., Edvardsson, C. E., Petrella, M., Jerlhag, E., Ericson, M., Söderpalm, B., & Adermark, L. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01887-2 · Cited by 14 · see citing works

Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour

Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110202 · Cited by 16 · see citing works

Chronic alcohol intake regulates expression of SARS‐CoV2 infection‐relevant genes in an organ‐specific manner

Friske, M. M., Giannone, F., Senger, M., Seitz, R., Hansson, A. C., & Spanagel, R. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14981 · Cited by 14 · see citing works

Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial

Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05502-y · Cited by 13 · see citing works

Chronic ethanol exposure produces sex-dependent impairments in value computations in the striatum

Cheng, Y., Magnard, R., Langdon, A., Lee, D., & Janak, P. H. (2025) · Science Advances · doi:10.1126/sciadv.adt0200 · Cited by 12 · see citing works

Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats

Jeanblanc, J., Bordy, R., Fouquet, G., Jeanblanc, V., & Naassïla, M. (2024) · Brain · doi:10.1093/brain/awae136 · Cited by 13 · see citing works

Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms

Meccia, J., Lopez, J., & Bagot, R. C. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06297-0 · Cited by 13 · see citing works

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence

Koning, E., & Brietzke, E. M. (2023) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2022-0597 · Cited by 13 · see citing works

Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches

Pich, E. M., Tarnanas, I., Brigidi, P., & Collo, G. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100713 · Cited by 13 · see citing works

Animal Models of Excessive Alcohol Consumption in Rodents

Becker, H. C., & Lopez, M. F. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_461 · Cited by 12 · see citing works

The psychedelic drug DOI reduces heroin motivation by targeting 5-HT2A receptors in a heroin and alcohol co-use model

Bonilla, J., Giannotti, G., Kregar, N. P., Heinsbroek, J. A., Olson, D. E., & Peters, J. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110163 · Cited by 11 · see citing works

Neuroprotective effects of psilocybin in a rat model of stroke

Yu, S., Wu, K., Wang, Y.-S., Bae, E., Chianelli, F., Bambakidis, N. C., & Wang, Y. (2024) · BMC Neuroscience · doi:10.1186/s12868-024-00903-x · Cited by 10 · see citing works

Classic psychedelics and the treatment for alcoholism

Lodetti, G., de Bitencourt, R. M., & Rico, E. P. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111129 · Cited by 11 · see citing works

A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse

Meinhardt, M. W., Skorodumov, I., Jeanblanc, J., Benvenuti, F., Hilal, F. F., Domi, E., André, C., Bodeau, S., Jeanblanc, V., Domanegg, K., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02071-w · Cited by 8 · see citing works

Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies

Hilal, F. F., Jeanblanc, J., Deschamps, C., Naassïla, M., Pierrefiche, O., & Hamida, S. B. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02757-3 · Cited by 8 · see citing works

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

Wittenkeller, L. M., Gudelsky, G. A., Winhusen, T. M., & Amato, D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70181 · Cited by 7 · see citing works

Ayahuasca for the treatment of alcohol use disorder

Marinho, E. A. V., Serra, Y. A., Oliveira-Lima, A. J., Marcourakis, T., & Berro, L. F. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.07.007 · Cited by 7 · see citing works

Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey

Roméo, B., Kervadec, E., Fauvel, B., Strika-Bruneau, L., Amirouche, A., Verroust, V., Piolino, P., & Benyamina, A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111300 · Cited by 7 · see citing works

Good Practice Guideline for Preclinical Alcohol Research: The STRINGENCY Framework

Meinhardt, M. W., Gerlach, B., & Spanagel, R. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_484 · Cited by 7 · see citing works

Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction

Habelt, B., Afanasenkau, D., Schwarz, C., Domanegg, K., Kuchař, M., Werner, C., Minev, I. R., Spanagel, R., Meinhardt, M. W., & Bernhardt, N. R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03189-z · Cited by 6 · see citing works

Alcohol-Induced Changes in Brain Microstructure: Uncovering Novel Pathophysiological Mechanisms of AUD Using Translational DTI in Humans and Rodents

Sommer, W. H., & Canals, S. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_585 · Cited by 6 · see citing works

Disrupted circadian expression of β‐arrestin 2 affects reward‐related µ‐opioid receptor function in alcohol dependence

Meinhardt, M. W., Giannone, F., Hirth, N., Bartsch, D., Spampinato, S. M., Kelsch, W., Spanagel, R., Sommer, W. H., & Hansson, A. C. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15559 · Cited by 6 · see citing works

Psychedelics for treating psychiatric disorders: from circuit mechanisms to applications

Li, J., Jiang, Y., Cheng, D., Cheng, J., Ji, H., Wang, X., & Yuan, T. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.11.033 · Cited by 5 · see citing works

The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review

Palmer, C., Ferber, A. T., & Greenwald, B. D. (2025) · Brain Sciences · doi:10.3390/brainsci15060572 · Cited by 5 · see citing works

Neurobiological substrates of altered states of consciousness induced by high ventilation breathwork accompanied by music

Kartar, A. A., Horinouchi, T., Örzsik, B., Anderson, B., Hall, L., Bailey, D., Samuel, S., Beltran, N., Bouyagoub, S., Racey, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329411 · Cited by 5 · see citing works

The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder

Pagni, B. A., Wong, J. M., & Bogenschutz, M. P. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00581-z · Cited by 5 · see citing works

The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review

Venugopal, K., & Bedri, N. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.420 · Cited by 5 · see citing works

Molecular Imaging Studies of Alcohol Use Disorder

Bach, P., de Timary, P., Gründer, G., & Cumming, P. D. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_414 · Cited by 5 · see citing works

Psychedelics for military and Veteran communities? Research, practice, and policy considerations

Shore, R. (2023) · Journal of Military Veteran and Family Health · doi:10.3138/jmvfh.9.5.ed01 · Cited by 4 · see citing works

A Model Guided Approach to Evoke Homogeneous Behavior During Temporal Reward and Loss Discounting

Thome, J., Pinger, M., Halli, P., Durstewitz, D., Sommer, W. H., Kirsch, P., & Koppe, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.846119 · Cited by 4 · see citing works

The utility of 2,5-dimethoxy-4-iodoamphetamine for the study of serotonin 2A and 2C receptors

Cameron, L. P., Jaster, A. M., Ramos, R., & Ullman, E. Z. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100093 · Cited by 3 · see citing works

Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa

McCoy, K., Reed, F. M., Conn, K., & Foldi, C. J. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.114957 · Cited by 3 · see citing works

Intérêt et mécanismes d’action de la kétamine dans le traitement de l’addiction à l’alcool – Revue des études cliniques et précliniques

Hilal, F. F., Jeanblanc, J., & Naassïla, M. (2023) · Biologie Aujourd hui · doi:10.1051/jbio/2023028 · Cited by 3 · see citing works

The Continuing Challenges of Studying Parallel Behaviours in Humans and Animal Models

Crombag, H. S., Duka, T., & Stephens, D. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_485 · Cited by 3 · see citing works

Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice

Pohořalá, V., Kuchař, M., Spanagel, R., & Bernardi, R. E. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.09.006 · Cited by 3 · see citing works

Schrooms against booze: Potential of mycotherapy for the treatment of AUD

Meinhardt, M. W., & Sommer, W. H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01446-7 · Cited by 3 · see citing works

Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer’s disease comorbidities?

Davidson, M., Stanciu, G. D., Rabinowitz, J., Untu, I., Dobrin, R., & Tamba, B.-I. (2025) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2025.2480566 · Cited by 3 · see citing works

mGlu2 Receptors in the Basal Ganglia: A New Frontier in Addiction Therapy

Mao, L., Puthumana, E. A., & Wang, J. Q. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26637 · Cited by 2 · see citing works

Chronic alcohol-induced brain states limit propagation of direct cortical stimulation

Habelt, B., Talebi, N., Afanasenkau, D., Schwarz, C., Knauer, B., Meinhardt, M. W., Spanagel, R., Werner, C., Minev, I. R., Beste, C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-21802-z · Cited by 2 · see citing works

New Approaches to Addiction Treatment Based on Learning and Memory

Bach, P., & Kiefer, F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_457 · Cited by 2 · see citing works

Generalized habitual tendencies in alcohol dependent rats

Giannone, F., Hach, A., Chrószcz, M., Friske, M. M., Meinhardt, M., Spanagel, R., Sommer, W. H., & Hansson, A. C. (2023) · Alcohol · doi:10.1016/j.alcohol.2023.03.106 · Cited by 2 · see citing works

Chronic Ethanol Exposure Produces Persistent Impairment in Cognitive Flexibility and Decision Signals in the StriatumPreprint

Cheng, Y., Magnard, R., Langdon, A., Lee, D., & Janak, P. H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.10.584332 · Cited by 2 · see citing works

Species differences in comorbid alcohol use disorder and major depressive disorder: A narrative review

Winkler, G. A., & Grahame, N. J. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70015 · Cited by 1 · see citing works

Disrupted decision making in adult male rats after prolonged withdrawal from ethanol vapor exposure

Cheng, Y., Kalapatapu, N., & Janak, P. H. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70143 · Cited by 1 · see citing works

Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms

Domi, A., Lucente, E., Cadeddu, D., Bengtsson, N., Smedler, E., & Adermark, L. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110854 · Cited by 1 · see citing works

Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials

McManus, K. R., & Ray, L. A. (2026) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2026.2625341 · Cited by 1 · see citing works

Efectos del alcohol sobre el metabolismo a través de la acetil-Coenzima A sintetasa: revisión sistemática y metanálisis

Souza-Silva, G., Felipe, M. P., Silva, P. V. G. D., & Ribeiro, A. F. (2022) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e10119.2022 · Cited by 1 · see citing works

Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models

Ezeaka, U. C., Kim, H. J. J., & Laprairie, R. B. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230705151922 · Cited by 1 · see citing works

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority TrialPreprint

Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3829237/v1

Traitements psychédéliques et soins en addictologie

Dauré, C., & Mallet, L. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77934-3.00069-x

Psilocybin in the Management of Substance Use Disorders: A Summary of Current Evidence

Bourji, H. E., Farhat, A., Hamdan, Z., Satodiya, R. M., Shukla, R., & Hayek, S. E. (2024) · Current Psychopharmacologye · doi:10.2174/0122115560288779240628043307

Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications

Tewfik, G., Adaralegbe, A., Gomez, S., Aziz, R., Chaudhry, F. A., Rodriguez-Correa, D. T., & Adaralegbe, D. O. (2024) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2024.101514

AI maps psychedelic ‘trip’ experiences to regions of the brain – opening new route to psychiatric treatments

Ballentine, G., & Friedman, S. F. (2022) · doi:10.64628/aai.txkhqrcfy

Behavioural investigations of psilocybin in non-human animals 1962–2021: A scoping review

Shore, R., Dobson, K., Thomson, N., Barnim, N., Bergman, H. P., Rideout, K., McKeown, S., Olmstead, M. C., Goldie, C. E., & Dumont, É. C. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00364

Psychedelics for the Treatment of Substance Use Disorder

Fumàs, B., Pubill, D., López‐Arnau, R., & Nadal‐Gratacós, N. (2025) · Pharmaceutical science. · doi:10.5772/intechopen.1012870

The Potential Therapeutic Effects of MEAI in the Treatment of Alcohol Use Disorder

Ekhlasi, M., Frytz, A., & Nia, A. B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00700-4

Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortexPreprint

Houff, J., Williams, A., Allen, O., Gisabella, B., Pantazopoulos, H., & Arco, A. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.22.696123

Investigating metabotropic glutamate receptors as molecular targets for next-generation pharmacotherapies for alcohol use disorder

Obraitis, D., Barry, J., & Li, D. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2675555

Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex

Houff, J., Williams, A., Allen, O., Gisabella, B., Pantazopoulos, H., & Arco, A. D. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70574

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats

Lodetti, G., de Bitencourt, R. M., Inserra, A., Redivo, H., Teixeira, A. G., de Farias, A. C. S., Pickler, K. D. P., Rohling, J. P. V., Endler, A. T., Zampronio, E. P., et al. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111817

Profiling the effects of alcohol history on cognitive performance during abstinence: an examination of proenkephalin-A-derived peptides in the medial prefrontal cortex

Melendez-Perdomo David, E., Asokan, M., Askins, L. A., Floresco, S., & Natividad, L. A. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111202

A common molecular mechanism for cognitive deficits and craving in alcoholismPreprint

Meinhardt, M. W., Pfarr, S., Rohleder, C., Vengeliene, V., Barroso-Flores, J., Hoffmann, R., Meinhardt, M. L., Paul, E. R., Hansson, A. C., Köhr, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.13.200519

Rescue of Infralimbic mGluR2Deficit Restores Control Over Drug-Seeking Behavior in Alcohol Dependence

Meinhardt, M. W., Hansson, A. C., Perreau‐Lenz, S., Bauder-Wenz, C., Stählin, O., Heilig, M. A., Harper, C. G., Drescher, K. U., Spanagel, R., & Sommer, W. H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4062-12.2013 · Cited by 170 · see citing works

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism

Domanegg, K., Sommer, W. H., & Meinhardt, M. W. (2023) · Cells · doi:10.3390/cells12060963 · Cited by 24 · see citing works

Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction

Habelt, B., Afanasenkau, D., Schwarz, C., Domanegg, K., Kuchař, M., Werner, C., Minev, I. R., Spanagel, R., Meinhardt, M. W., & Bernhardt, N. R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03189-z · Cited by 6 · see citing works

Schrooms against booze: Potential of mycotherapy for the treatment of AUD

Meinhardt, M. W., & Sommer, W. H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01446-7 · Cited by 3 · see citing works